首页>
外国专利>
DRY EYE THERAPEUTIC AGENT HAVING AS ACTIVE INGREDIENT NANDROLONE OR ESTER THEREOF OR METHENOLONE OR ESTER THEREOF
DRY EYE THERAPEUTIC AGENT HAVING AS ACTIVE INGREDIENT NANDROLONE OR ESTER THEREOF OR METHENOLONE OR ESTER THEREOF
展开▼
机译:具有活性成分的双环龙酮或酯类或甲萘醌或酯类的干眼治疗剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
An object of the present invention is to provide a novel dry eye therapeutic agent that demonstrates superior dry eye therapeutic effects, and from the viewpoint of the drug administration burden of the patient, is capable of demonstrating a medicinal effect over a long period of time in lacrimal gland tissue after the administration thereof. A dry eye therapeutic agent comprising nandrolone or an ester thereof or methenolone or an ester thereof is therapeutically effective on dry eye since it increases the amount of tear lipocalin (TL) in tears, and medicinal effects can be demonstrated over a long period of time in lacrimal gland tissue by administering a dry eye therapeutic agent comprising nandrolone or an ester thereof or methenolone or an ester thereof to eyelid skin.
展开▼